Immune function status of postoperative patients with colon cancer for predicting liver metastasis

Table 3 Efficacy analysis of the relationship between immune-related and tumor-related indicators in predicting liver metastasis in colon cancer

Indicator	AUC	95% CI for AUC	Standard error	P value	Cut-off value	Sensitivity	Specificity
CEA	0.956	0.927-0.984	0.014	< 0.001	4.170	0.990	0.770
CA19-9	0.986	0.972-1.000	0.007	< 0.001	21.820	0.990	0.640
CA242	0.987	0.976-1.000	0.006	< 0.001	89.915	0.990	0.420
CA72-4	0.990	0.976-1.000	0.007	< 0.001	28.625	0.990	0.150
CA50	0.912	0.872-0.952	0.020	< 0.001	28.985	0.990	0.780
CD3+	0.912	0.870-0.954	0.021	< 0.001	46.925	0.990	0.900
CD4+	0.978	0.962-0.995	0.008	< 0.001	26.725	0.990	0.480
CD8+	0.869	0.820-0.917	0.025	< 0.001	19.290	0.990	0.900
NK	0.980	0.965-0.995	0.008	< 0.001	32.430	0.990	0.370
CD4+/CD25	0.870	0.818-0.922	0.027	< 0.001	0.015	0.990	0.990

AUC: Area under curve; CEA: Carcinoembryonic antigen; NK: Natural killer.